Research compound profile
BPC-157
Body protection compound fragment · synthetic pentadecapeptide — preclinical research context
BPC-157 is described in the scientific literature as a synthetic pentadecapeptide named in relation to stable gastric “body protection compound” protein fragments—not as an approved drug on this site. Most published work is animal and in vitro; human trial readouts, where they exist, belong in primary sources and regulatory filings, not in catalog copy. NEXT lists materials for authorized research use only—not for human or veterinary treatment, consumer injection guidance, or compounding for patients.
Compound specifications
Mechanism — research framing
- Angiogenesis / VEGF narratives: Some rodent papers report vascular growth-factor–related readouts after experimental protocols—endpoints vary by dose route, species, and injury model.
- Nitric oxide system: Literature discusses NO pathways in the context of vascular tone and healing models; mechanisms remain partly contested.
- Extracellular matrix & collagen assays: Tendon, ligament, and wound models measure histology or biomechanics under controlled conditions—not predictive for purchased materials.
- GI mucosa & NSAID-toxicity models: A common preclinical thread in publications; regulatory status of any related drug program is separate from RUO catalog listings.
Areas of research interest (literature)
- Soft-tissue and musculoskeletal injury endpoints in animals (protocol design drives outcomes).
- Ischemia–reperfusion and vascular integrity themes as reported in specialized papers.
- Behavioral or neuropharmacology studies citing blood–brain barrier questions—species and compound handling differ widely.
- Co-administration or “stack” narratives in preclinical work; interaction risk is not generalized from blogs.
- Analytical characterization (LC-MS, purity, counterion, stability) for laboratory inventory control.
Peptide regulations & site policy
- RUO: Materials are sold for research use only. They are not drugs, supplements, or cosmetics for human or animal use unless your program holds all required authorizations.
- FDA / FTC: Investigational compounds are not FDA-approved for the uses discussed in lay media. This page is educational; it does not diagnose, treat, cure, or prevent any disease.
- No clinical instructions: NEXT does not provide dosing, reconstitution for injection in humans, cycle advice, or prescribing information.
- Jurisdiction: Import, possession, and use of research peptides are regulated differently by country and state. You are responsible for lawful conduct in your location.
- COA & chain of custody: Batch documentation is provided per catalog policy; storage, handling, and record-keeping are your laboratory’s responsibility.
- Wholesale / retail paths: Volume and institutional purchasing follow B2B membership rules after approval; retail checkout follows discount membership and storefront terms.